To investigate whether PTBP3 mediates gallbladder cancer immune escape via ΔIL‐18, we overexpressed PTBP3 in tumor cells and treated them with ASO4 to reduce ΔIL‐18 production. Here, PTBP3 is linked to gallbladder cancer.